SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-017093
Filing Date
2024-02-20
Accepted
2024-02-20 16:05:54
Documents
83
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K idya-20231231.htm   iXBRL 10-K 3457086
2 EX-4.3 idya-ex4_3.htm EX-4.3 45650
3 EX-10.13 idya-ex10_13.htm EX-10.13 29351
4 EX-10.23 idya-ex10_23.htm EX-10.23 561841
5 EX-10.25 idya-ex10_25.htm EX-10.25 735262
6 EX-23.1 idya-ex23_1.htm EX-23.1 2623
7 EX-31.1 idya-ex31_1.htm EX-31.1 16373
8 EX-31.2 idya-ex31_2.htm EX-31.2 16155
9 EX-32.1 idya-ex32_1.htm EX-32.1 13872
10 EX-97 idya-ex97.htm EX-97 45602
11 GRAPHIC img41158376_0.jpg GRAPHIC 596332
12 GRAPHIC img268055577_0.jpg GRAPHIC 178545
13 GRAPHIC img268055577_1.jpg GRAPHIC 80918
  Complete submission text file 0000950170-24-017093.txt   13932324

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT idya-20231231.xsd EX-101.SCH 1292982
85 EXTRACTED XBRL INSTANCE DOCUMENT idya-20231231_htm.xml XML 1531760
Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

IRS No.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38915 | Film No.: 24653238
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)